Swedencare - A run-of-the-mill quarter with 400% growth (ABG Sundal Collier)
2021-07-29 21:52
Solid report across the board
Optimistic comments around synergies and targets
Adj. EBIT estimates up 1-3%
Key takes from the Q2’21 reportSwedencare’s Q2’21 report was strong, although the company continues to see supply chain issues. Sales grew 45% organically (ABGSCe: 45%) and 400% in total to SEK 160m, 2% below our expectations at SEK 163m. The growth within the group companies is stated to have varied from single digits to almost triple digits, with the companies seeing single-digit growth rates having the most supply troubles – one of the reasons the Vetio acquisition was made. On the margin, the company reported a 28% adj. EBIT margin, which was above our expectations and resulted in an adj. EBIT beat of 7%.
Outlook: Stronger Vetio performance and faster synergies
While we saw no drama in the reported numbers, we have a few key take-aways from the conference call, which has resulted in us raising our ‘23e EBIT by 3%. 1) The Vetio order visibility looks even stronger than we thought, with Vetio North having a higher share of development revenues likely to turn into manufacturing during 2022-2023. On the back of this, we raise our organic growth assumptions for the company by 5pp in H2’22-‘23e to c. 20%. 2) Insourcing synergies are likely to materialise earlier than our initial expectations. On the conference call, management stated that they target 50% of US production to be insourced in 12 months, indicating faster synergies in Rx than our earlier expectations. On the back of this, we raise our ’21-‘23e sales and EBIT by 0-4% and 1-3%, respectively. 3) The company will review its financial targets during H2. While we believe the margin target is likely to stay, the review could result in a bump to the sales level, which now implies a 20% CAGR on our 2023 estimates.
Trading at 41x EV/EBIT 2023e
On our updated estimates, the Swedencare share is trading at a ‘21e-‘23e EV/EBIT of 72-41x. This corresponds to the share trading 35-25% above animal health peers and 34-29%
...
- Läs mer på Introduce
Läsaren av innehållet kan anta att ABG Sundal Collier har erhållit eller kommer att erhålla betalning för utförandet av finansiella företagstjänster från bolaget. Ersättningen är på förhand avtalad och är inte beroende av innehållet.
research@abgsc.com (Introduce.se)
ABG Sundal Collier - Introduce.se